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1  |  INTRODUC TION
Stroke incidence and mortality is decreasing across the developed 
world, although the ageing of the population is offsetting some of 
the decline in age- adjusted incidence rates. Furthermore, stroke 
outcomes have seen substantial improvement since the introduction 
of thrombolytic treatment, and later endovascular thrombectomy. 
These novel treatment options have increased the emphasis on 
timely arrival to hospital and the stroke unit (SU) to ensure an opti-
mal regime with the resulting improvement of prognosis – that time 
is brain has become doxa.1 Moreover, health authorities in several 
countries have rolled out mass media information (MMI) campaigns 
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Objectives: The objective was to quantify temporal trends in stroke mimics (SM) ad-
missions relative to cerebrovascular accidents (CVA), incidence of hospitalized SMs 
and characterize the SM case- mix at a general hospital's stroke unit (SU).
Materials & Methods: All SU admissions (n = 11240) of patients aged 15 or older to 
Haukeland University Hospital between 2008– 2017 were prospectively included and 
categorized as CVA or SM. Logistic regression was used to estimate time trends in the 
proportion of SMs among the admissions. Poisson regression was used to estimate 
time trends in age- and sex- dependent SM incidence.
Results: SMs were on average younger thaan CVA patients (68.3 vs. 71.4 years) and 
had a higher proportion of females (53.6% vs. 44.5%). The total proportion of SM 
admissions was 51.0%. There was an increasing time trend in the proportion of SM ad-
missions, odds ratio 1.150 per year (p < 0.001), but this trend appears flattening, rep-
resented by a significant quadratic time- term, odds ratio 1.009 (p < 0.001). A higher 
SM proportion was also associated with the time period of a Mass Media Intervention 
(FAST campaign) in 2014. There was also an increasing trend in SM incidence, that 
remains after adjusting for age, sex, and population; also, for incidence the trend ap-
pears to be flattening.
Conclusions: SMs account for approximately half of the SU admissions, and the pro-
portion has been increasing. A FAST campaign appears to have temporarily increased 
the SM proportion. The age- and sex- dependent incidence of SM has been increasing 
but appears to flatten out.
K E Y W O R D S
epidemiology, peripheral vertigo, stroke, stroke mimics, stroke unit
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directed towards the general public, in particular Face- Arm- Speech- 
Time (FAST) campaigns, with the aim of educating citizens about 
stroke symptoms and the importance of admission without de-
lay.2– 5 In brief, modern stroke treatment at a specialized SU6,7 sig-
nificantly benefits stroke patients,7– 10 but is demanding on limited 
resources.6,9,11,12
Stroke mimics (SMs) are defined as symptoms that are mistaken 
for acute stroke as the admission diagnosis, and which later are re-
vised to a definite or more probable alternative diagnosis. Several 
studies have reported on the number of patients that ultimately 
were identified with SMs, but the settings and figures vary substan-
tially between studies.13,14 Peripheral vertigo, migraine and other 
headaches, epilepsy, and a host of other conditions are regularly 
initially misidentified as acute stroke or transient ischaemic attack 
(TIA).15– 17 Additionally, studies specifically addressing SMs have 
focused on the case- mix of SMs,15,18 the safety of thrombolysis in 
these cases,19- 23 the difficulties in determining if symptoms were 
a TIA or not,24 and some studies also highlight that admitting SMs 
to the SU is costly.17,25 A recent study specifically aimed at looking 
at the economic burden of stroke mimics also published several ex-
trapolated scenarios on the number of stroke mimics in the years to 
come.17 The difficulty of distinguishing SMs from stroke symptoms 
and TIAs has attracted sustained attention.23,26– 29
However, to our best knowledge, no study has hitherto analysed 
temporal trends as the main outcome with time series of SM admis-
sions,30 although Terrin et al. did correlate date of publication with 
share of SM reported.31 To address this knowledge gap we analysed 
a data set of 5 720 SM admissions to the SU of a large Norwegian 
university hospital during a 10- year period. The aim of this study is 
to investigate temporal trends in the period 2008– 2017 in the rel-
ative share of patients admitted to SUs with SMs, and to estimate 
incidence rates for SU admission of SMs.
2  |  MATERIAL S & METHODS
The present study is based on data from a prospective, single- centre 
study undertaken at Haukeland University Hospital (HUS), Bergen, 
Norway. The data underlying the analysis comprises all patients 
aged 15 or older admitted to the comprehensive SU at HUS with 
suspected acute stroke or TIA, and includes first- ever, recurrent, 
fatal, and non- fatal cases: the unit of analysis is ‘admittance to the SU, 
after initial assessment by neurologist in the ED. Data from the 10- year 
period 2008– 2017 was analysed. Throughout this period, the use 
of MRI for this patient group has been close to 90% at HUS32; most 
patients were assessed by 1.5T, and only a minority have had 3T 
examination. It is not registered in our data whether 1.5T or 3T ex-
amination were used, but there has been no systematic change in 
the use of 1.5T or 3T during the study period. There has been no 
change in the medical competence at the ward: the senior physi-
cians have been largely the same individuals, with many remaining 
throughout the whole period, and all included patients were as-
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a stroke neurologist, was consulted in cases of doubt prior to admis-
sion to the SU. An inexperienced junior doctor will consult with a 
senior physician prior to all SU admittances.
HUS is the primary acute hospital for inhabitants in 24 munici-
palities in Vestland County, corresponding a catchment area of 4.7% 
of the Norwegian person years (PYs) for the period under study. The 
total population increased from 216 335 to 248 023 during the study 
period, and accounts for a total of 2.3 M PYs. In Norway, all non- 
elective inpatient admissions – including suspected strokes/TIAs – 
are handled by the public health care system, and there is choice of 
hospital of admittance: which hospital a patient is sent to is defined 
exclusively by suspected diagnosis and the patient's location at the 
time the need for medical attention arise. As such, there is no self- 
selection present in the data, and a patient with suspected stroke 
is always taken to the nearest hospital. In addition to residents of 
HUS’s catchment area, HUS also admits patients who are candidates 
for thrombectomy from the surrounding Vestland county, in addition 
to lodging individuals (eg staying at a hotel or with family). Similarly, 
patients resident in HUS’s catchment area who experience a (sus-
pected) stroke while travelling will be admitted to the local hospital 
at the location of lodging.
The discharge diagnoses were first dichotomized into either 
cerebrovascular accident (CVA) – comprising ischaemic stroke (IS), in-
tracerebral haemorrhage (ICH), transient ischaemic attack (TIA), and 
other cerebrovascular events (OCE; including spinal infarctions, amau-
rosis, and unspecified stroke) – or, as stroke mimics (SMs).
All SM diagnoses were set by the same neurologist (HN), who 
also classified all CVA diagnoses. KWF independently sub- classified 
the SMs into 20 categories (See Table 2) based on previous litera-
ture, in order to facilitate comparisons.13,17,18,25,29,30,33,34
To conduct the analyses, three different data sets were used: 
(i) The NORSTROKE registry has prospectively registered all ad-
missions to Haukeland University Hospital's SU since 2008 until 
the present. All SU admission for TIAs and strokes between 2008 
and 2017 were used for the present analyses..35 Variables extracted 
were: age at admission, sex, month and year of admission, diagnosis; 
(ii) data for the admissions resulting in a non- stroke diagnosis – the 
SMs of interest here – were only available on paper forms. These 
were entered into a separate data base for this study. Variables ex-
tracted were age at admission, sex, month and year of admission, 
and diagnosis. (iii) from Statistics Norway we extracted the number 
of inhabitants of age ≥ 15 within HUS’ catchment area (by age and 
sex).
Detailed information on handling of missing data (year of admis-
sion for some SM’s had not been entered at the forms) is described 
in an appendix (Appendix I).
In addition to descriptive statistics,36 we analysed the time trend 
in the relative share of SMs in the SU and the time trend in the inci-
dence of SM admissions to the SU.
The time trend of the relative share of SM admissions was ana-
lysed with a binary logistic regression model, which estimates the 
probability that an admission is a SM, given the calendar time of 

















































































































































































































































































































































































































































































































































































































    |  5BARRA et Al.
beginning of the study period (2008). In addition, we included a qua-
dratic time- term (t2) to represent changes to the time trend over the 
period.
Lastly, we hypothesized that an MMI campaign in May 2014 could 
have increased admittances for SMs, and therefore included an indi-
cator dummy for this effect. We based the selection of this dummy 
on Advani et al.'s finding that the campaign's effect on decreased 
prehospital delay was noticeable for 6 month.4 The campaign was 
described as ‘with a precampaign month, priming the treatment chain 
and raising in- hospital awareness[,]’ so we coded this variable to indi-
cate the months April– September 2014.
While the SM share model estimates the frequency of SM ad-
mission relatively to the total frequency of admissions to the SU, 
the incidence model estimates the number of SM admissions relative 
to the number of people in the hospital's catchment area. For this 
we used Poisson regression,37 which estimates the number of SM 
admissions through year t from a population Pa,s,t of patients with 
age a and sex s. With the predictors age (a), sex (s) and year (t), the 
functional form of the expected number of admissions is given by:
Here, t is the main coefficient of interest, which represents the 
time trend. Note that the exponential function ensures positive esti-
mates and that the Pa,s,t term ensures proportionality with the popu-
lation size. The basic regression formula above was expanded by the 
inclusion of a quadratic year- term (t2 t2), a quadratic age- term (a2a2), 
and interaction terms of sex with all the other predictors (effectively 
estimating separate models for each sex).
About 5% of the admissions in the data set pertained to indi-
viduals not residing in HUS’ catchment area. The purpose of the 
incidence analysis was to estimate the number of admissions that 
can be expected from a population of a given size. While some non- 
HUS- area residents present with SM at HUS, some HUS- area resi-
dents will surely be hospitalized with SMs at other hospitals. Since 
we have no reason to assume that either group is larger, we decided 
to include the non- HUS patients in our incidence estimates.
To perform further sub- analyses, we conducted an explorative 
analysis on the SM subcategories, looking for evidence for tempo-
ral trends in age- and sex- adjusted incidence rates, with a particular 
focus on peripheral vertigo, headaches including migraine, and symp-
toms involving the nervous system, as these diagnoses are known to 
dominate amongst the stroke mimics.16 The use of the diagnoses 
observation for suspected nervous system disorder (ICD- 10: Z03.3) and 
sequela after stroke (ICD- 10: I69.1 and I69.3) were also considered in 
more detail. As the use of observation for suspected nervous system 
disorder can represent any of the other mimics,17 it is important to 
consider the temporal trends in its use to mitigate spurious trends 
in other mimics. For example, a decrease in the use of Z0.03 could 
explain an increase in other mimics.
We assessed the models with standard fitness statistics (R2, AIC/
BIC, and cross- validation routines).
All analyses were performed with the statistical software R (ver-
sion 4.0.2) in the RStudio environment (version 1.2.5001),38 relying 
on the Plotly, sjPlot, and Stargazer packages for graphing rendering 
and tabulating regression outputs.
3  |  RESULTS
There was a total of 11 240 SU admissions recorded during the study 
period: 5 732 SM admissions (51.0%) and 5 508 CVA admissions 
SMa,s,t = exp(0 + aa + ss + tt)Pa,s,t .
F I G U R E  1  Plot of the share of admissions resulting in a mimic diagnosis, by month 2008– 2017. The sizes of the markers are proportional 
to the number of admissions it represents. Traces correspond to the predictions by binary logistic regression models (2) and (4) (Table 4) and 
includes the effect of the MMI (visible as an elevated plateau April– September 2014)
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(49.0%). Descriptive statistics for the full sample of SU admissions 
(including CVAs) are provided in Table 1.
The number of SU admissions increased by 55.0% between 2008 
and 2017, and the increase was higher for SMs (89.6%) than for CVAs 
(29.3%). Much of the absolute increase in SU admissions can be ex-
plained by both an increase and an ageing of HUS’s catchment area 
(please see the subsection on incidence modelling below). The mean 
age of patients with CVAs appeared stable, while it decreased for 
patients with SMs.
Table 2 provides a break- down of the admissions by year and SM 
subcategories. The most common subcategories were headaches in-
cluding migraine (18.7%), peripheral vertigo (15.4%) and observation for 
suspected nervous system disorder (10.9%). Table 2 also reports infor-
mation about evidence for temporal trends for the SM subcategories 
(see also the section on regression modelling below).
3.1  |  Mimics admissions' share of total 
SU admissions
Aggregating the admission counts (AC) for each of the 120 months 
in the 10- year period results in month- specific total, SM and CVA 
admission, and is plotted by month in Figure 1. We observe markedly 
more variance in the number of SM admissions than for CVA admis-
sions: the range of mimic admissions in a given month is 2– 80, while 
CVA admissions are in the range 28– 68.
The main regression models that test if there is a significant 
temporal trend in the share of mimic admissions are presented in 
Table 3. Several specifications were tested: With and without a 
quadratic time- term, and with and without the MMI- dummy. The 
best fits were specifications which account for the regional MMI in 
May 2014. The regression analysis finds strong evidence for an in-
creasing trend in the share of SMs. The share of SMs predicted by 
the models that include the MMI- dummy– models (2) and (4) – are 
plotted in Figure 1.
The share of SM admissions within each 10- year age bracket, 
for each year, is provided in a Table in an appendix (Table S3). For 
all age brackets below 65– 74, the number of SMs exceeds the num-
ber of CVAs. Furthermore, an ad hoc regression analysis predicting 
share of SMs by year for each of the age brackets, suggests that 
the increase is most pronounced in the middle brackets 35– 74, ex-
cept 45– 54.
3.2  |  Incidence modelling
In Table 4 we give sex- specific, observed incidence rates (per 100k 
PY) for SU admissions and broken down into SM admissions and 
CVA admissions.
The regression modelling of incidence found no temporal trend 
in overall CVA incidence, but the expected highly significant effect 
of age and sex was observed (see Table S4). Regarding the incidence 
model for SM admissions, there was no significant difference in the 
temporal trends between the sexes (indicated by the nonsignifi-
cant sex- time interactions). The coefficients on both time and time 
squared were highly significant and exhibit the same pattern as for 
the share of all admissions that were due to SMs: a highly signif-
icant increasing temporal trend with additional evidence for that 
TA B L E  3  Regression results. Each model is a binary logistic regression of a dummy for SM status (SM = 1, CVA = 0) against an intercept 
(intercept) and time (t)
Dependent variable:
SM
Model (1) (2) (3) (4)
Variable Regression coefficientsa 
Intercept −0.222*** −0.227*** −0.422*** −0.395***
(95%CI) (−0.303, −0.141) (−0.308, −0.146) (−0.547, −0.297) (−0.521, −0.269)
t 0.048*** 0.046*** 0.159*** 0.140***
(95%CI) (0.035, 0.062) (0.033, 0.059) (0.105, 0.213) (0.085, 0.195)
MMI 0.325*** 0.266**
(95%CI) (0.160, 0.491) (0.097, 0.435)
t2 −0.011*** −0.009***
(95%CI) (−0.016, −0.006) (−0.014, −0.004)
Observations 11 240 11 240 11 240 11 240
AIC 15 530 15 517 15 515 15 507
A dummy MMIcoding for an hypothesized 6- month effect from the Mass Media Intervention in May 2014 for stroke awareness described in Advani 
et al. (coded as 1 for April– September 2014) is included in models (2) and (4). A squared time- term (t2) is included in models (3) and (4) to account for a 
dampening or acceleration of the temporal term. (95%CI) is the confidence interval for the regression coefficients of the coefficient.
*p < 0.05, **p < 0.01, ***p < 0.001.
aTo obtain ORs, exponentiate the regression coefficients.
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this trend has either peaked or is flattening. Unlike for CVAs, males 
appear to start out with a lower SM- admission rate than females – 
negative sex- coefficient – but the sex- difference diminishes with 
age, and changes sign between 54 and 55 years of age, after which 
females have a lower age- adjusted admission rate for SMs.
The model’s predictions are plotted in Figure 2.
3.3  |  Subcategories
We next fitted Poisson regression models for each of the 24 sub-
categories of diagnoses (four CVA subcategories and the 20 SM 
subcategories; see Table 2) both without and with a quadratic tem-
poral trend. For the interpretation of the regression results there 
are therefore several caveats. Due to the high number of tests (48), 
we employed Bonferroni- correction when interpreting the results,39 
using p < 0.05
48
 = 0.0010 as the significance level.
With this correction in place, we still found a significant, increas-
ing, temporal trend for the following SM subcategories: peripheral 
vertigo, headaches including migraine, epilepsy or seizures, symptoms 
involving the nervous system, diseases of the peripheral nervous sys-
tem, and observation for suspected nervous system disorder. Among 
these, the trends for headache- and for the observation diagnoses 
displayed evidence for a flattening of the trend (negative coefficient 
for the quadratic time- term,) but the increase in the remaining ap-
pear to be ongoing. Furthermore, age was positively associated with 
admission for all categories. Among the SMs, male sex was positively 
associated only with SU admission for intoxications, extra cranial hae-
morrhages, epilepsy and seizures, and CVA sequela; female sex was 
associated with SU admission for headaches including migraine. Due 
TA B L E  4  Observed age- specific incidences of SU admissions, CVA admissions, and SM admissions for the period 2008– 2017
Observed incidence per 100k PYs
Age Sex
SU 
admissions SM admissions CVA admissions PYs
15– 24 Male 27.59 19.98 7.61 210,247
15– 24 Female 44.59 36.26 8.33 204,071
15– 24 All 35.96 28.00 7.96 414,318
25– 34 Male 64.52 45.33 19.19 244,892
25– 34 Female 97.32 83.10 14.22 225,039
25– 34 All 80.22 63.41 16.81 469,931
35– 44 Male 140.71 96.88 43.84 228,127
35– 44 Female 148.80 112.44 36.36 209,004
35– 44 All 144.58 104.32 40.26 437,131
45– 54 Male 338.91 185.17 153.74 203,596
45– 54 Female 261.24 184.96 76.28 191,392
45– 54 All 301.27 185.07 116.21 394,988
55– 64 Male 745.24 337.38 407.86 146,128
55– 64 Female 450.94 285.43 165.51 142,590
55– 64 All 599.89 311.72 288.17 288,718
65– 74 Male 1618.05 650.58 967.47 83,310
65– 74 Female 1096.04 595.06 500.98 91,420
65– 74 All 1344.93 621.53 723.40 174,730
75– 84 Male 3073.09 1244.82 1828.26 44,906
75– 84 Female 2247.10 1083.11 1163.99 63,059
75– 84 All 2590.65 1150.37 1440.28 107,965
85– 94 Male 4624.39 1966.85 2657.55 15,202
85– 94 Female 3690.81 1728.80 1962.00 32,161
85– 94 All 3990.46 1805.21 2185.25 47,363
95– 105+ Male 3869.05 2232.14 1636.90 672
95– 105+ Female 3417.90 1162.79 2255.11 2838
95– 105+ All 3504.27 1367.52 2136.75 3510
15– 105+ Male 490.45 225.90 264.55 1,177,080
15– 105+ Female 470.65 264.55 206.10 1,161,574
15– 105+ All 480.62 245.10 235.52 2,338,654
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to the problem with multiple testing, and the fact that some of the 
SM subcategories had a low number of admissions, we did not con-
duct further explorations (eg an age sex interaction) as was done for 
the full model (Table S4). See supplementary Appendix II for more 
detailed regression output for the subcategory analyses (Tables S5 
and S6).
4  |  DISCUSSION
In this study, we have found strong evidence for a substantial and 
significant increase in the SMs’ share of the SU case- mix at a large 
Norwegian university hospital: from just below 43% in 2008 and 
up to 52% in 2017. Furthermore, we can assert that this increase 
is not due to changing demographics between SM and CVA: as the 
incidence of SU admission for SMs increase adjusted for age and 
sex, and the age profile for incidences are similar between SMs and 
CVAs. We cannot conclude that this increase is set to continue, as 
we find evidence that this trend might have peaked.
Increased emphasis on stroke as a medical emergency and 
the ‘time is brain’ paradigm after the breakthrough of intravenous 
thrombolytic therapy has likely resulted in a lower threshold for ad-
missions to an SU for suspected strokes and TIAs. For example, TIAs 
were not routinely admitted to hospitals in Norway prior to 2011, 
and there is evidence that milder strokes (NIHHS at arrival) are hos-
pitalized more often than two decades ago.40 An almost inevitable 
consequence of such a medically desired intake policy is an increase 
in ED and SU admissions for patients who prove to have other condi-
tions than acute stroke. Another way to view this is that if the health 
system's sensitivity for stroke increase, then the specificity must 
almost surely suffer somewhat. However, SU beds are resource con-
suming; hence, it is important to evaluate the use of SU beds and to 
monitor temporal trends. In this study, SMs outnumbered CVA ad-
missions already in 2011 – and has not declined since – although we 
observe a flattening during the latter part of the 10- year period. We 
strongly suspect that the paradigm shift in acute stroke treatment 
needs to be followed up by diagnostic tools that have better speci-
ficity for stroke. This study indicates that an increased sensitivity of 
the Norwegian health care system to detect and admit stroke likely 
comes at the cost of a lowered specificity.
The overall CVA incidence rate was comparable to other data.41 
Interestingly, the SM incidence rate was about the same as the CVA 
incidence. By using Faiz et al.'s estimates for hospital length of stay 
(LOS) for TIA, IS, ICH and SM admissions, a 50% share of SM's trans-
lates into a 20% increase in the demand for SU beds, when consid-
ering that SM admissions have shorter LOS. The implication is that 
health authorities risk a serious discrepancy between SU- demand 
and SU capacity if hospitalization of stroke mimics are not factored 
into administrative estimates. Furthermore, SMs require assess-
ment from physicians and allied health personnel and radiological 
investigations. Importantly, patients with SMs will potentially re-
ceive delayed diagnostic investigation and treatment for their actual 
condition, for example their infection, epileptic seizure or migraine 
attack. With limited MRI capacity, incidental imaging findings might 
lead to unnecessary control regimes and overtreatment.42,43
Several studies have focused on safety and cost burden in the 
hyperacute stroke setting regarding provision of intravenous throm-
bolytic therapy to patients with SMs.20,22,25,44,45 With an ageing 
population over the next decades combined with improvements in 
disease prevention and treatment, stroke is one of the diseases that 
F I G U R E  2  The plots show Poisson regression estimates for incidence rates for males (blue) and females (red) for stroke mimics; 2008, 
thin lines; 2017, thicker lines. We see that male risk for SM overtakes female risk for SM by the age of 54. (Plot based on regression omitting 
nonsignificant sex- year interactions, for model output, see supplementary Table S4.)
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has caused concern. One reason for this concern is that the absolute 
number of stroke events may increase due to demographic changes, 
despite a reduction in age- and sex- adjusted incidence rates, which 
eventually will require more resources and hospital capacity. A sub-
stantial part of this capacity is now occupied with patients with SMs.
Previous publications on SMs have highlighted a higher pro-
portion of female and younger patients compared to patients with 
CVA.13,14,30,31,33 Our study is consistent with such findings, but with 
several caveats, and our results nuances this picture. For example, 
we do observe a higher SM admission rate for female than male 
patients, but only among the younger patients. The sex- difference 
diminishes with age, and after the age of 50 years, males have the 
highest age- adjusted SM admission rate; just as for CVAs. While most 
patents with SMs are female in the lower and the upper age groups, 
for 44– 65- year- olds only 47% of the are female. Furthermore, ad-
vanced age only weakly predicted CVA. Even among the 85+ year- 
olds, 4 out of 10 SU admissions were caused by SMs. This illustrates 
that SMs provide for a complicating factor on the SUs, where the 
conditional pre- diagnostic probabilities for SM versus CVA can be 
non- trivial to disentangle, and where conventional age- or sex- based 
intuitions may fail; indeed, we were surprised ourselves by some of 
our findings.
It is often challenging to compare SM proportions between stud-
ies because of different health care organization, including admis-
sion threshold, patient populations, time periods and SM definitions. 
In a recent study from Japan evaluating the 10- year period 2007– 
2016, 23.5% of the patients (348/1482) were diagnosed with stroke 
mimics (compared to our 51.0%),46 but the study did not analyse 
temporal trends during the 10- year period. Another study evaluat-
ing a 10- year period (2001– 2010) from the United States reported a 
SM proportion of 30.0% (2454/8187).30 In the most recent system-
atic review, SM proportions varied between 3% and 64%.14
MMIs have previously been shown to have a substantial, but 
time- limited effect,4 on stroke knowledge and prehospital delay. In 
our study, we had a predefined hypothesis that a specific MMI in-
tervention in 2014 increased the SM proportion in the following six 
months. Our regression analyses confirmed this with an estimated 
substantial and statistically significantly (p = 0.002) increased share 
(about 10%) of SMs in the given time period.
Moreover, during the 10- year period presented in this study, 
new national stroke guidelines were published in 2011, that em-
phasized the hospitalization also of TIA patients. A national clinical 
stroke registry with various quality indicators was implemented in 
2013, and in 2017 a national stroke pathway with additional quality 
indicators was introduced. In addition to a regional MMI in 2014, a 
national MMI on both linear media and social media was initiated 
in October 2016. Taken together, increased focus on acute stroke 
during this period, though guidelines, increased reporting of quality 
indicators such as prehospital delay, and MMIs, may be underlying 
drivers that have resulted in an increase in SM SU admissions as a 
side effect.3,4,47 That these efforts may already have come into ef-
fect by the end of the period under study also fit with an initially 
steeper increase, and a levelling out towards the end.
Some studies have highlighted functional mimics as an important 
subgroup of the SMs.33,48 In our study, only about 1% of the SMs 
were psychiatric disorders, but 15.6% of the SM admissions did not 
get an exact diagnosis, rather a symptom- based or an observational 
diagnosis. We suspect that a proportion of these patients could have 
functional SMs. Importantly, some of the mimic subgroups were sta-
ble during the 10- year period, while others, such as headaches, pe-
ripheral vertigo and epilepsy/seizures, increased significantly. This is 
consistent with the systematic reviews of SM case- mix when taking 
into account that we only find significant increasing incidence of SU 
admission for vertigo, headaches, symptoms involving the nervous 
system, and epilepsy.
We were also concerned with monitoring the possible shift be-
tween SM subcategories. For example, decline in the use of either 
observation for suspected nervous system disorder or other diagnoses 
could both explain an increase in other SM subcategories, say pe-
ripheral vertigo, and represent a welcomed result of more specific 
diagnosing. Instead, we observed that, by and large, there was no 
evidence that the incidence of the hospitalization of any SM subcate-
gory were declining, and that admissions classified as observation for 
suspected nervous system disorder increased. (Appendix II).
TIA admission incidence also increased enough to suggest a pos-
sible increasing temporal trend, albeit not significant when applying 
the Bonferroni- correction for multiple testing (p = 0. 03; Appendix 
II). Furthermore, if present, it seems to level out at the end of the 
period under study. This observation is consistent with an increased 
awareness of the importance of fast admission to an SU also for 
TIAs and milder strokes following the rTPA revolution of the early 
2000s. The CVA sequela subcategory displayed the expected male 
sex association, consistent with male sex increased risk for CVAs. No 
discernible temporal trend for CVAs was observed, which is consis-
tent with the stable or declining stroke incidence rates observed in 
Norway.49,50
Our study has several implications for SU physicians and for 
policy makers. In the clinical setting, the staff should be aware that 
despite improved diagnostics and imaging, SU intake appears to be 
less specific for stroke than ten years ago. An awareness of this phe-
nomenon could help guide the work- up and target the patients with 
highest pre- test probability of presenting with mimics on the SU.
4.1  |  Strengths and limitations
This study is conducted at a large Norwegian university hospital 
with little self- selection (no private alternative). The data were col-
lected prospectively, and longitudinal data for a relatively long time 
period (10 years) strengthens the results. In addition, we present the 
first time trend analysis of SM admissions to the SU. One important 
limitation is that the data are from a single- centre, external validity 
is therefore questionable. Different health care systems, guidelines, 
intake criteria, and referral practices might interact with the pro-
cess of admission to an SU in different ways. We did not have ad-
ditional information on SMs, such as types and degree of symptoms 
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and disability, or previous medical history including typical stroke 
risk factors, which prevents our study from contributing to more 
accurate discrimination between SMs and stroke. However, we do 
believe that our findings should be of interest, and that our results, 
viewed in conjunction with the recent surge in interest for SMs, in-
dicate that the observed trend might not be specific to our centre 
or country.
5  |  CONCLUSIONS
SMs’ share of the case- mix of SU admissions appears to have seen 
a substantial and highly significant increase over the past dec-
ade in our stroke centre, and this finding cannot be explained by 
a demographic shift. The share of SMs has risen to above 50%. 
Our results are inconclusive as to whether the observed surge 
in SMs at the stroke unit is levelling out or continuing to climb, 
and we caution others to extrapolate our findings into the future. 
While male sex is a predictor for CVA- caused SU admissions, pa-
tients on the SU with SMs are more often female. However, older 
males have a higher risk of being admitted to an SU with an SM 
than females of the same age, although the sex- imbalance in the 
Norwegian population offsets this risk to the extent that most 
SMs are female. Young age at SU admissions is predictive of an SM 
diagnosis. In absolute terms, most SU admissions for SMs involve 
a patient of age 67 or older (50.5%). There is a substantial varia-
tion in the risk profiles, according to SM subcategory, and age. The 
observed increase in SMs— both incidences and proportion of SU 
admissions— is attributable mainly to peripheral vertigo, headaches, 
epilepsy, nervous system symptoms, and observation diagnoses. We 
venture to recommend that it would not be prudent to scale down 
on SU capacity based on declining CVA incidences alone. Further 
trends in SU capacity demand should be monitored closely by 
health care administrators and policy makers, and we encourage 
further investigation of SM incidences, as well as intensified re-
search into more accurate initial diagnostics for suspected acute 
CVA to alleviate the SUs.
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